Natera Inc (NTRA)
Natera Inc (NTRA) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.
As of Oct 23, 2026: market cap $58.2B; returns 1 day +0.6%, 1 week +2.7%, 1 year +107.2%.
Natera, Inc. is a global leader in cell-free DNA (cfDNA) testing and precision medicine, focusing on oncology, women's health, and organ health. The company develops and commercializes genetic testing technologies for clinical applications.
Groups NTRA belongs to
- Healthcare
- Biotechnology
- Precision Medicine
- Oncology
- Women's Health
- Organ Transplantation
- Life Sciences
- Health Diagnostics and Imaging
- Medical Devices
- Early Cancer Detection
- Clinical Stage
- Healthcare Technology
NTRA financial model: income statement, cash flow and balance sheet